Apoptosis signal-regulating kinase inhibitor
US9750730B2 · kind B2 · utility
6Cited by
2References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Sep 5, 2017 |
| Priority date | — |
| Expiry date | Apr 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of formula (I):The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.